Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Cambrex Corporation

TRADE

NYSE: CBMHealthcare / Biotechnology / USA
58.50-1.50-2.50%Vol 348 3921Y Perf 12.93%
Oct 17th, 2018 16:02
BID58.49 ASK58.50
Open59.93 Previous Close60.00
Pre-Market- After-Trading58.50
 - -%  - -%
Target Price
69.17 
Analyst Rating
Strong Buy 1.33
Potencial %
18.24 
Finscreener Ranking
★★★★★     60.83
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
★★★★+     64.12
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
★★★★★     70.22
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)1 946 
Earnings Rating
Price Range Ratio 52wk %
59.34 
Earnings Date
6th Nov 2018

Today's Price Range

58.1759.93

52wk Range

42.5569.43

5 Year PE Ratio Range

5.3033.80

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-5.95%
3 Months
3.82%
6 Months
6.36%
1 Year
12.93%
3 Years
30.38%
5 Years
253.69%

Quotes

Name / TickerPriceChg.Chg.%
CBM58.50-1.5000-2.50
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.00
Current Ratio 5.20
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage 374.70
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin41.00
EBIT Margin26.40
EBITDA Margin31.80
Pre-tax Profit Margin19.90
Profit Margin22.76
ValuationValueIndustryS&P 500US Markets
PE Ratio 16.50
PB Ratio 3.21
PS Ratios 4.34
Price to Cash Flow 15.60
Price to Free Cash Flow 41.90
Cash Flow Per Share 3.85
Price to Tangible Book3.53
Book Value per Share18.74
Enterprise Value (in ths.)1 831 800
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)21.34
ROE last 12 Months 22.10
Return on Assets (5Y Avg) 8.67
ROA last 12 Months 16.06
Return on Capital (5Y Avg) 18.37
ROC last 12 Months 22.31
Return on invested Capital Q 6.65
Return on invested Capital Y21.56
Assets Turnover0.60
Receivables Turnover3.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)461 849
Revenue per Share 13.89
Revenue Growth 3 Years 5.51
Revenue Growth 5 Years 11.16
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 20180.661.2183.33
Q01 20180.500.7244.00
Q04 20171.101.2715.45
Q03 20170.470.5517.02
Q02 20170.750.761.33
Q01 20170.510.6833.33
Q04 2016-1.18-
Q03 2016-0.44-
Earnings Per EndEstimateRevision %Trend
9/2018 QR0.59-6.35Negative
12/2018 QR1.1958.67Positive
12/2018 FY2.823.30Positive
12/2019 FY2.85-3.72Negative
Next Report Date6th Nov 2018
Estimated EPS Next Report0.59
Estimates Count1
EPS Growth Next 5 Years %10.00
Volume Overview
Volume348 392
Shares Outstanding (in ths.)33 260
Trades Count1 837
Dollar Volume16 594 840
Avg. Volume346 163
Avg. Weekly Volume457 198
Avg. Monthly Volume402 395
Avg. Quarterly Volume375 015

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

61%39%

Bearish Bullish

44%56%

Bearish Bullish

51%49%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (83.33 %)
4 (80.00 %)
4 (80.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (16.67 %)
1 (20.00 %)
1 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.33
Strong Buy
1.40
Strong Buy
1.40

There are no comments yet.

News

x